Cargando…

Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients

BACKGROUND: Cardiac autonomic neuropathy (CAN) is a common complication of diabetes associated with poor prognosis. In addition, the autonomic imbalance is associated with cardiovascular disease (CVD) in diabetes. It is thought that adipocytokines contribute to the increased risk of vascular complic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Chan-Hee, Kim, Bo-Yeon, Kim, Chul-Hee, Kang, Sung-Koo, Jung, Sang-Hee, Mok, Ji-Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353195/
https://www.ncbi.nlm.nih.gov/pubmed/22413919
http://dx.doi.org/10.1186/1475-2840-11-24
_version_ 1782233008745480192
author Jung, Chan-Hee
Kim, Bo-Yeon
Kim, Chul-Hee
Kang, Sung-Koo
Jung, Sang-Hee
Mok, Ji-Oh
author_facet Jung, Chan-Hee
Kim, Bo-Yeon
Kim, Chul-Hee
Kang, Sung-Koo
Jung, Sang-Hee
Mok, Ji-Oh
author_sort Jung, Chan-Hee
collection PubMed
description BACKGROUND: Cardiac autonomic neuropathy (CAN) is a common complication of diabetes associated with poor prognosis. In addition, the autonomic imbalance is associated with cardiovascular disease (CVD) in diabetes. It is thought that adipocytokines contribute to the increased risk of vascular complications in patients with type 2 diabetes mellitus (T2DM). However, literature data on the association between CAN with adipocytokines such as leptin, tumor necrosis factor-alpha (TNF-alpha), adiponectin in subjects with T2DM is limited. Therefore, in the present study, we examined the relationship between fasting serum leptin, TNF- alpha and adiponectin and CAN in Korean T2DM patients. METHODS: A total of 142 T2DM patients (94 males, 48 females) were recruited. CAN was assessed by the five tests according to the Ewing's protocol and the time and frequency domain of the heart rate variability (HRV) was evaluated. Serum TNF-alpha and adiponectin levels were measured using enzyme-linked immunosorbent assay and serum leptin levels were measured using radioimmunoassay. RESULTS: Although, the mean levels of leptin, TNF-alpha and adiponectin were not significantly different between the groups with and without CAN, the levels of leptin and adiponectin had a tendency to increase as the score of CAN increased (p = 0.05, p = 0.036). Serum leptin levels demonstrated a negative correlation with low frequency (LF) in the upright position (p = 0.037). Regarding TNF-alpha, a significant negative correlation was observed with SDNN and RMSSD in the upright position (p = 0.023, p = 0.019). Adiponectin levels were not related to any HRV parameters. Multivariate logistic regression analysis demonstrated that the odds of CAN increased with a longer duration of diabetes (1.25, [1.07-1.47]) and higher homeostatic model of assessment-insulin resistance (HOMA-IR) (5.47, [1.8-16.5]). The relative risks for the presence of CAN were 14.1 and 51.6 for the adiponectin 2(nd), 3(rd )tertiles when compared with first tertile (p-value for trend = 0.022). CONCLUSIONS: In the present study, the higher serum adiponectin levels and HOMA-IR were associated with an increased risk for the presence of CAN. Also, the CAN score correlated with the serum adiponectin. Serum adipocytokines such as leptin and TNF-alpha were significantly correlated with parameters of HRV, representative markers of CAN. Future prospective studies with larger number of patients are required to establish a direct relationship between plasma adipocytokine concentrations and the development or severity of CAN.
format Online
Article
Text
id pubmed-3353195
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33531952012-05-16 Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients Jung, Chan-Hee Kim, Bo-Yeon Kim, Chul-Hee Kang, Sung-Koo Jung, Sang-Hee Mok, Ji-Oh Cardiovasc Diabetol Original Investigation BACKGROUND: Cardiac autonomic neuropathy (CAN) is a common complication of diabetes associated with poor prognosis. In addition, the autonomic imbalance is associated with cardiovascular disease (CVD) in diabetes. It is thought that adipocytokines contribute to the increased risk of vascular complications in patients with type 2 diabetes mellitus (T2DM). However, literature data on the association between CAN with adipocytokines such as leptin, tumor necrosis factor-alpha (TNF-alpha), adiponectin in subjects with T2DM is limited. Therefore, in the present study, we examined the relationship between fasting serum leptin, TNF- alpha and adiponectin and CAN in Korean T2DM patients. METHODS: A total of 142 T2DM patients (94 males, 48 females) were recruited. CAN was assessed by the five tests according to the Ewing's protocol and the time and frequency domain of the heart rate variability (HRV) was evaluated. Serum TNF-alpha and adiponectin levels were measured using enzyme-linked immunosorbent assay and serum leptin levels were measured using radioimmunoassay. RESULTS: Although, the mean levels of leptin, TNF-alpha and adiponectin were not significantly different between the groups with and without CAN, the levels of leptin and adiponectin had a tendency to increase as the score of CAN increased (p = 0.05, p = 0.036). Serum leptin levels demonstrated a negative correlation with low frequency (LF) in the upright position (p = 0.037). Regarding TNF-alpha, a significant negative correlation was observed with SDNN and RMSSD in the upright position (p = 0.023, p = 0.019). Adiponectin levels were not related to any HRV parameters. Multivariate logistic regression analysis demonstrated that the odds of CAN increased with a longer duration of diabetes (1.25, [1.07-1.47]) and higher homeostatic model of assessment-insulin resistance (HOMA-IR) (5.47, [1.8-16.5]). The relative risks for the presence of CAN were 14.1 and 51.6 for the adiponectin 2(nd), 3(rd )tertiles when compared with first tertile (p-value for trend = 0.022). CONCLUSIONS: In the present study, the higher serum adiponectin levels and HOMA-IR were associated with an increased risk for the presence of CAN. Also, the CAN score correlated with the serum adiponectin. Serum adipocytokines such as leptin and TNF-alpha were significantly correlated with parameters of HRV, representative markers of CAN. Future prospective studies with larger number of patients are required to establish a direct relationship between plasma adipocytokine concentrations and the development or severity of CAN. BioMed Central 2012-03-13 /pmc/articles/PMC3353195/ /pubmed/22413919 http://dx.doi.org/10.1186/1475-2840-11-24 Text en Copyright ©2012 Jung et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Investigation
Jung, Chan-Hee
Kim, Bo-Yeon
Kim, Chul-Hee
Kang, Sung-Koo
Jung, Sang-Hee
Mok, Ji-Oh
Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
title Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
title_full Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
title_fullStr Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
title_full_unstemmed Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
title_short Association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
title_sort association of serum adipocytokine levels with cardiac autonomic neuropathy in type 2 diabetic patients
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353195/
https://www.ncbi.nlm.nih.gov/pubmed/22413919
http://dx.doi.org/10.1186/1475-2840-11-24
work_keys_str_mv AT jungchanhee associationofserumadipocytokinelevelswithcardiacautonomicneuropathyintype2diabeticpatients
AT kimboyeon associationofserumadipocytokinelevelswithcardiacautonomicneuropathyintype2diabeticpatients
AT kimchulhee associationofserumadipocytokinelevelswithcardiacautonomicneuropathyintype2diabeticpatients
AT kangsungkoo associationofserumadipocytokinelevelswithcardiacautonomicneuropathyintype2diabeticpatients
AT jungsanghee associationofserumadipocytokinelevelswithcardiacautonomicneuropathyintype2diabeticpatients
AT mokjioh associationofserumadipocytokinelevelswithcardiacautonomicneuropathyintype2diabeticpatients